Prospera Financial Services Inc
Position in ABOS — Acumen Pharmaceuticals, Inc.
CIK 1541625
Dallas, TX
Position in ABOS
as of Mar 31, 2026
· filed Apr 14, 2026
Position Value
$118,000
+$12,500 QoQ
Shares Held
50,000
0.0% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 84 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Prospera Financial Services Inc holds $12,879,194 across 15 Biotechnology names. ABOS ranks #12 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
77,622 | $3,943,197 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,667 | $3,605,910 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
173,051 | $1,105,795 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,360 | $1,053,834 | |
| 5 | PLX |
Protalix BioTherapeutics, Inc.
|
418,570 | $908,296 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
20,998 | $697,553 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
17,492 | $380,625 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
4,341 | $325,965 |
All Filings in ABOS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $118,000 | 50,000 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $105,500 | 50,000 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||